Stoke Therapeutics STOK
NASDAQ STOK
$27.14 -0.07 (-0.28%)
As of: Nov 11, 2026 · 12:03 PM EST

Stoke Therapeutics (STOK) Long-Term Investments (2024 - 2026)

Updated

Analysis

Stoke Therapeutics (STOK) Long-Term Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Stoke Therapeutics 1.76 Bn 523.36 Mn - 39.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 39.60 Mn
Jun 30, 2026 61.50 Mn
Mar 31, 2026 67.48 Mn
Dec 31, 2025 106.26 Mn
Sep 30, 2025 80.32 Mn
Jun 30, 2025 107.26 Mn
Mar 31, 2025 22.99 Mn
Dec 31, 2024 29.82 Mn
Sep 30, 2024 29.95 Mn
API Access

Stoke Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=STOK&period=max&api_key=YOUR_API_KEY